ES2126644T3 - Reactivo en fase solida y dosificado anticorporal que lo utiliza. - Google Patents

Reactivo en fase solida y dosificado anticorporal que lo utiliza.

Info

Publication number
ES2126644T3
ES2126644T3 ES93903313T ES93903313T ES2126644T3 ES 2126644 T3 ES2126644 T3 ES 2126644T3 ES 93903313 T ES93903313 T ES 93903313T ES 93903313 T ES93903313 T ES 93903313T ES 2126644 T3 ES2126644 T3 ES 2126644T3
Authority
ES
Spain
Prior art keywords
phase reagent
anticorporal
dosage
solid phase
antibody specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903313T
Other languages
English (en)
Inventor
Takao Koike
Eiji Matsuura
Yoshiko Igarashi
Hisato Nagae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of ES2126644T3 publication Critical patent/ES2126644T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN ANTICUERPO ESPECIFICO PARA UN SINDROME DE ANTICUERPO ANTIFOSFOLIPIDO PUEDE SER PROBADO ESPECIFICAMENTE USANDO UN REACTIVO DE FASE SOLIDA ENLAZANDO (BETA)2-GLICOPROTEINA I A UN PORTADOR QUE TIENE UN GRUPO FUNCIONAL Y/O UN RADICAL LIBRE CON UNA CARGA NEGATIVA O UN PAR DE ELECTRONES AISLADOS UNIDOS A SU SUPERFICIE. TAMBIEN UN ANTICUERPO ESPECIFICO PARA UN SINDROME DE ANTICUERPO ANTIFOSFOLIPIDO Y OTRO ANTICUERPO ESPECIFICO PARA UNA ENFERMEDAD INFECCIOSA PUEDE SER DETECTADO DIFERENCIALMENTE USANDO EL REACTIVO ANTERIOR O UNA MODIFICACION DE EL.
ES93903313T 1992-02-05 1993-02-05 Reactivo en fase solida y dosificado anticorporal que lo utiliza. Expired - Lifetime ES2126644T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5432992 1992-02-05
JP23651792 1992-08-12

Publications (1)

Publication Number Publication Date
ES2126644T3 true ES2126644T3 (es) 1999-04-01

Family

ID=26395081

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903313T Expired - Lifetime ES2126644T3 (es) 1992-02-05 1993-02-05 Reactivo en fase solida y dosificado anticorporal que lo utiliza.

Country Status (9)

Country Link
US (1) US5472883A (es)
EP (1) EP0600088B1 (es)
JP (1) JP2886983B2 (es)
AT (1) ATE175275T1 (es)
AU (1) AU666352B2 (es)
CA (1) CA2107557C (es)
DE (1) DE69322842T2 (es)
ES (1) ES2126644T3 (es)
WO (1) WO1993016387A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7707294A (en) * 1993-09-29 1995-04-18 Yamasa Corporation Method of assaying oxidized lipoprotein and application thereof
WO1995014231A1 (en) * 1993-11-16 1995-05-26 Yamasa Corporation Method of assaying antiphospholipid antibody and kit therefor
JP3359415B2 (ja) 1994-03-17 2002-12-24 積水化学工業株式会社 抗リン脂質抗体測定用免疫診断薬の製造方法
ATE225041T1 (de) * 1994-08-01 2002-10-15 Inst Rech Developpement Ird Verfahren zur trennung und/oder identifikation und/oder quantifizierung von infektiösen materialen und träger zur durchführung dieses verfahrens
FR2723204B1 (fr) * 1994-08-01 1996-10-11 Orstom Procede de detection et/ou de dosage de compose(s) infectueux dans un materiau biologique et support utilise pour ledit procede
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
BR9713852A (pt) * 1996-12-05 2000-10-31 Idego Aps Laminado sensor, processos para produção de um laminado sensor e para detecção de uma molécula alvo selecionada em um fluido biológico, mecanismo de liberação de fluido multiseccionado, e, kit para detecção de uma molécula alvo selecionada em um fluido biológico.
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US6777193B1 (en) * 2000-08-04 2004-08-17 Escuela Nacional De Ciencias Biologicas, Del Instituto Politecnico Nacional Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices
ES2239532B1 (es) * 2004-02-06 2006-11-01 Proyecto De Biomedicina Cima S.L. Metodo para evaluar el riesgo y la predisposicion a desarrollar una patologia relacionada con la presencia de autoanticuerpos frente a epcr.
US7273998B2 (en) * 2004-09-15 2007-09-25 General Electric Company System and method for monitoring laser shock processing
DK1853631T3 (en) * 2005-01-24 2016-03-29 Univ Texas Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
WO2006109312A2 (en) * 2005-04-15 2006-10-19 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
IT202100002306A1 (it) * 2021-02-03 2022-08-03 Univ Degli Studi Roma La Sapienza Procedimento e kit per la diagnosi in vitro della sindrome da anticorpi anti-fosfolipidi

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
JPS5915861A (ja) * 1982-07-19 1984-01-26 Konishiroku Photo Ind Co Ltd 免疫分析用材料
US4552633A (en) * 1982-09-29 1985-11-12 Japan Atomic Energy Research Institute Fine particulate for use in clinical testing and a process for producing thereof
JPS5958004A (ja) * 1982-09-29 1984-04-03 Japan Atom Energy Res Inst 臨床検査用微粒子の製造方法
JPS6091983A (ja) * 1983-10-25 1985-05-23 Susumu Kogyo Kk タンパク質固定用膜担体およびその製造方法
SE8401437D0 (sv) * 1984-03-14 1984-03-14 Sven Gothe Ytmodifierade plastytor och dess tillempningar for immunoassays (ia)
JPS60260857A (ja) * 1984-06-08 1985-12-24 Sumitomo Bakelite Co Ltd 固相免疫測定法用成形品
JPS62123359A (ja) * 1985-11-22 1987-06-04 Sumitomo Bakelite Co Ltd 固相免疫測定用成形品及びその製造方法
JPS6318268A (ja) * 1986-07-10 1988-01-26 Olympus Optical Co Ltd 生化学分析用担体およびその製造方法
ATE84149T1 (de) * 1987-08-04 1993-01-15 Sohrab Darougar Photographische fluoreszenzimmunanalyse.
JPH01223352A (ja) * 1988-01-11 1989-09-06 General Biometrics Inc 固相酵素免疫検定システムおよび方法
US5028657A (en) * 1988-07-18 1991-07-02 Industrial Research Technology Institute Use of plasma to immobilize protein on polymeric surfaces
US5171779A (en) * 1988-07-18 1992-12-15 Industrial Technology Research Institute Use of plasma to immobilize protein on polymeric surfaces
JPH0271152A (ja) * 1988-09-07 1990-03-09 Terumo Corp 固相免疫測定用成形品の製造法
US5102798A (en) * 1988-09-08 1992-04-07 Allage Associates Surface functionalized Langmuir-Blodgett films for immobilization of active moieties
US5016644A (en) * 1989-01-10 1991-05-21 La Mina Ltd. Urine testing module and method of collecting urine antigen
US4961432A (en) * 1989-01-10 1990-10-09 Cancer Diagnostics, Inc. Modular fluid sample preparation assembly
DE69029873T2 (de) * 1989-05-02 1997-08-07 Abbott Lab Kovalente Kupplung von spezifischen Bindungspartnern an einer Festphase
US5133363A (en) * 1989-06-21 1992-07-28 La Mina Ltd. Modular multiple fluid sample preparation assembly
JP2714862B2 (ja) * 1989-08-11 1998-02-16 日東電工株式会社 免疫学的測定法
EP0425268A3 (en) * 1989-10-27 1992-03-25 Teijin Limited Phosphazene polymer carrier for biologically active substance
CA2058769C (en) * 1990-04-06 1999-03-02 Steven Anthony Krilis Methods for determining phospholipids and antibodies thereof

Also Published As

Publication number Publication date
ATE175275T1 (de) 1999-01-15
JP2886983B2 (ja) 1999-04-26
DE69322842D1 (de) 1999-02-11
CA2107557A1 (en) 1993-08-06
AU3463393A (en) 1993-09-03
CA2107557C (en) 1999-07-20
WO1993016387A1 (en) 1993-08-19
US5472883A (en) 1995-12-05
EP0600088B1 (en) 1998-12-30
EP0600088A4 (en) 1996-08-21
DE69322842T2 (de) 1999-05-20
AU666352B2 (en) 1996-02-08
EP0600088A1 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
ES2126644T3 (es) Reactivo en fase solida y dosificado anticorporal que lo utiliza.
DE3761489D1 (de) Transporteinrichtung mit rollensystemen fuer vakuum-beschichtungsanlagen.
FI950002L (fi) Anti-HCV-vasta-aineiden immunomääritykset käyttäen antigeenejä joissa on konformaatioepitooppeja
DE3861063D1 (de) Unabhaengige aufladevorrichtung fuer transportflugzeuge.
DK157805C (da) Apparat til transport af tung last.
DE3867600D1 (de) Verbrennungsvorrichtung fuer pulverisierte kohle.
DE68901784D1 (de) Zuglasche fuer reissverschlussschieber.
FI791594A7 (fi) Kuljetuslaite ripustuselimellä varustettua kuljetuskannatinta varten.
DE3869031D1 (de) Detektor fuer geladene teilchen.
FI924641L (fi) Monoklonala antikroppar mot hepatit c-virus
ATA74890A (de) Abscheider fuer leichtfluessigkeiten
FR2649528B1 (fr) Conteneur de transport d'elements de combustible nucleaire
FI793158A7 (fi) Laite henkilöiden ja tavaroiden siirtämiseksi vedessä liikkuvaan rakenteeseen tai siitä pois.
DE3874913D1 (de) Beleuchtungsvorrichtung fuer ein mehrfarbenkopiergeraet.
IT8921152A0 (it) Unita' di trasporto stradale a carrozzeria portante deponibile.
DE3770879D1 (de) Differential-summierverstaerker fuer eingangsspannungen mit grossem gleichtaktanteil.
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
EP0183215A3 (en) Method for determination of herpes simplex virus antibodies
IT8740140A0 (it) Dispositivo meccanico conglobante le funzioni di differenziale autobloccante e ripartitore di coppia secondo un rapporto determinato tra i due semialberi
DE3861917D1 (de) Tiefladewaggon fuer huckepackverkehr.
FR2580563B1 (fr) Dispositif pour manipuler une charge notamment pour vehicules de transport
JPS593334U (ja) 光源方位検出器付光学レンズ装置
IL101602A0 (en) Anti-viral hybrid antibodies
JPS5942038U (ja) ハイブリツドｉｃの搬送用ベルトコンベヤ
ZA946768B (en) Monoclonal antibodies responding to the surface antigens fo stromal cells

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600088

Country of ref document: ES